These processes involve AngII upregulation of TGFβ expression in both cardiomyocytes and cardiac fibroblasts and the resulting contributions of AngII and TGFβ signaling to fibrosis and cardiac hypertrophy as part of pathological ventricular remodeling [4]. The gene discussed is AGT; the disease is cardiac hypertrophy.